Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 638 of 6351
-
New vaccine aims to shield toddlers from 24 pneumonia strains
Vaccine Recruiting nowA Phase 1b clinical trial of 24-valent pneumococcal conjugate vaccine (PCV24) developed by Sinovac Life Science Co., Ltd will be conducted in pediatric population aged 2 months (minimum 42 days)-23 months. The objective of the study is to evaluate the safety and immunogenicity o…
Phase 1 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: Vaccine
Last updated Jun 27, 2026 09:00 UTC
-
New hope for hand function: Non-Invasive therapies tested in spinal cord injury
Disease control Recruiting nowThis study explores two promising therapies for restoring arm and hand function in people with chronic cervical spinal cord injury (SCI), a condition that affects independence and quality of life. It will compare transcutaneous spinal cord stimulation and paired corticospinal-mot…
Phase 2/3 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New Scan-Guided biopsy could catch hidden prostate cancers
Diagnosis Recruiting nowThe goal is to provide more accurate diagnostic tools and optimized diagnostic workflows for clinically suspected prostate cancer patients with prior negative biopsies, improving early detection rates for csPCa and reducing missed diagnoses.
Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
New drug cocktail aims to stall pancreatic cancer after chemo
Disease control Recruiting nowThe main goal of this study is to look at the effectiveness and anti-tumor activity (preventing growth of the tumor) of the drugs niraparib and ipilimumab, on the patients and their pancreatic cancer. This study will involve two different treatment arms. In Arm A, patients will r…
Phase 2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 26, 2026 17:32 UTC
-
Can a quick zapping of bone spots prevent fractures? new trial aims to find out
Disease control OngoingThis phase III trial compares the effect of adding radiation therapy to usual treatment on the occurrence of bone-related complications in cancer patients with high-risk bone metastases that are not causing symptoms, such as pain (asymptomatic). High-risk bone metastases are defi…
Phase 3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can a simple antibiotic or immunoglobulin shield blood cancer patients from deadly infections?
Disease control Recruiting nowThis study is being conducted to find out how safe and effective different strategies of infection prevention are in comparison to each other, for preventing infection in patients with blood cancers. The best way to find out this information is to directly compare the effect of d…
Phase 2/3 • Sponsor: Monash University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New trial aims to stop infections in blood cancer patients
Disease control Recruiting nowThis study is being conducted to find out how safe and effective different strategies of infection prevention are in comparison to each other, for preventing infection in patients with blood cancers. The best way to find out this information is to directly compare the effect of d…
Phase 2/3 • Sponsor: Monash University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could 'lung rest' on ECMO save more lives in severe ARDS?
Disease control Recruiting nowThe CALMDOWN trial is a prospective, open-label, multicenter, comparative, controlled trial randomizing patients who received near apneic ventilation vs usual care on ECMO (ultra-protective lung ventilation). The study goal is to investigate the benefit of early apneic ventilati…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New single-dose pill may beat week-long treatment for common STI
Cure Recruiting nowThis is a multi-centered, randomized, open-label, parallel, phase IV clinical trial comparing the effectiveness and cost-effectiveness of oral multi-dose metronidazole (MTZ) and oral single-dose secnidazole (SEC) for the treatment of Trichomonas vaginalis in both women and men.
Phase 4 • Sponsor: Tulane University • Aim: Cure
Last updated Jun 27, 2026 12:29 UTC
-
Could a single infusion of modified immune cells tame autoimmune attacks?
Disease control Recruiting nowThe main objective of the study is to determine the recommended phase 2 dose (RP2D) of Azercabtagene zapreleucel (azer-cel).
Phase 1 • Sponsor: TG Therapeutics, Inc. • Aim: Disease control
Last updated Sep 10, 2026 07:00 UTC
-
Can immunoglobulin or antibiotics stop infections in blood cancer patients?
Disease control Recruiting nowThis is an adaptive platform study to find out how safe and effective different strategies are in comparison to each other, for preventing infection in patients with blood cancers. It is a comparison between Immunoglobulin and antibiotics use.
Phase 2/3 • Sponsor: Monash University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug cocktail aims to outdo chemo for tough throat cancer
Disease control Recruiting nowThis is a randomized, open-label, multi-center, phase III study to evaluate the efficacy and safety, and immunogenicity of MRG003 in combination with pucotenlimab in patients with recurrent or metastatic nasopharyngeal carcinoma.
Phase 3 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Magnets to the brain: a new test for steadier steps in old age
Disease control Recruiting nowThe goal of this study is to learn if manipulating the brain using magnets works to treat balance impairment, a major cause of falls, in older adults with balance problems. The technique to manipulate the brain using magnets is known as transcranial magnetic stimulation or TMS. …
Early phase 1 • Sponsor: Weinberg Medical Physics LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a steroid injection tame the inflammation behind retinal detachment?
Disease control CompletedThis prospective, randomized, controlled clinical study evaluates the effects of preoperative intravitreal triamcinolone acetonide (TA) on growth factors and inflammatory mediators in patients with rhegmatogenous retinal detachment (RRD) and proliferative vitreoretinopathy (PVR).…
Sponsor: Anggun Rama Yudantha • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New drug could cut blood transfusions for MDS patients
Disease control Recruiting nowThe main aim of this study is to find out how well elritercept works in lowering the need for RBC transfusions. Other aims are to learn how well elritercept works in reducing the need for RBC transfusions over longer periods of time or in adults with high transfusion needs. The s…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New heart pump trial offers hope for advanced heart failure patients
Disease control Recruiting nowThe study is a prospective, multi-center, non-randomized trial to evaluate the safety and effectiveness of the CorWave LVAS for the treatment of advanced heart failure patients.
Sponsor: CorWave • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a new BTK inhibitor outsmart resistance in CLL?
Disease control Recruiting nowThis is a multicentre single-arm prospective phase II trial evaluating pirtobrutinib in the treatment of relapsed/refractory (R/R) Chronic Lymphocytic Leukaemia (CLL) patients who have previously received zanubrutinib, and to specifically evaluate Bruton Tyrosine Kinase (BTK) mut…
Phase 2 • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug combo aims to boost weight loss in obesity trial
Disease control OngoingThe main aim of the study is to assess the effect of RO7204239 in combination with tirzepatide, compared to placebo in combination with tirzepatide, on body weight loss after 48 weeks of treatment in adults with obesity or overweight with at least one weight-related comorbidity, …
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 10, 2026 07:00 UTC
-
New cell therapy trial aims to tame stubborn Crohn's
Disease control Recruiting nowThis research study is testing an investigational research product called TRX103 as a possible treatment for individuals suffering from Crohn's Disease (CD). The primary purpose of this study is to learn how safe and effective different doses of TRX103 are when administered to in…
Phase 1/2 • Sponsor: Tr1X, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New hope for lung scarring: SOLIS trial tests H01 drug
Disease control Recruiting nowBackground: Interstitial lung disease affects the tissues that aid the transfer of oxygen and carbon dioxide between the air and the bloodstream. The disease can cause fibrosis, a thickening and scarring of lung tissue. Fibrosis often continues getting worse, and most people wit…
Phase 2 • Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC